Crux Biomedical Inc., a Portola Valley, Calif.-based medical device startup from former NeoPath and Bacchus Vascular executive Mel Schatz, has raised around $3.85 million in Series A funding, according to a regulatory filing cited by PE Week. Backers include Alloy Ventures and Dr. Thomas Fogerty.
Update: We see that SiliconTap had the news first.
VentureBeatVentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative technology and transact. Our site delivers essential information on data technologies and strategies to guide you as you lead your organizations. We invite you to become a member of our community, to access:
- up-to-date information on the subjects of interest to you
- our newsletters
- gated thought-leader content and discounted access to our prized events, such as Transform 2021: Learn More
- networking features, and more